A Study to Assess the Pharmacokinetics, Metabolism and Excretion Routes of ASP3652 in Man, After Administration of 14C Radio Labeled ASP3652

NCT02046798 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Pharmacokinetics of ASP3652

Interventions

DRUG: ASP3652

Sponsor

Astellas Pharma Europe B.V.